Quality of life (QoL) assessment of insulin detemir and NPH human insulin in Japanese subjects with diabetes on basal-bolus regimen

被引：0

|

作者：

Ishii, Hitoshi

Iwamoto, Yasuhiko

Kaku, Kohei

Kawamori, Ryuzo

Tajima, Naoko

Kobayashi, Masashi

机构：

来源：

DIABETES | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A710 / A710

页数：1

相关论文

共 50 条

[21] Switching from an NPH Insulin to an Insulin Glargine Basal-Bolus Regimen Improves Glycemic Control in Diabetic Patients: The LINDA Study
Kvapil, Milan
Krivska, Bohumila
Avy, Zdenek Ru
DIABETES, 2011, 60 : A621 - A621
[22] Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study
Yenigun, M.
Honka, M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (03) : 425 - 432
[23] Insulin detemir reduces the risk of hypoglycaemia at all levels of HbA1c compared to NPH insulin in the context of basal-bolus therapy for type 1 diabetes
Jones, DR
Kim, H
Heller, S
Clauson, P
DIABETOLOGIA, 2005, 48 : A92 - A93
[24] Insulin analogues (insulin detemir and insulin aspart) in comparison with traditional human insulin (NPH-insulin and short-acting human insulin) in basal bolus therapy of type 1 diabetes mellitus
Khermansen, K.
Fonten, P.
Kukolyya, K. K.
Peterkova, V. A.
Leyt, G.
Gall, M.
DIABETES MELLITUS, 2006, 9 (01): : 18 - 26
[25] Beyond basal-bolus insulin regimen: Is it still the ultimate chance for therapy in diabetes? Comment
Giugliano, Dario
Bellastella, Giuseppe
Maiorino, Maria Ida
Esposito, Katherine
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
[26] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
Tejera, Cristina
Miguel Morales, Francisco
Maria Lopez, Ana
Galvan, Beatriz
Delgado, Esther
Beato, Pilar
Hernandez, Virginia
DIABETES, 2014, 63 : A596 - A596
[27] Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus
Heller, Simon
Bode, Bruce
Kozlovski, Plamen
Svendsen, Anne Louise
JOURNAL OF DIABETES, 2013, 5 (04) : 482 - 491
[28] Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen
Kato, Tomoko
Tokubuchi, Ichiro
Muraishi, Kazuhisa
Sato, Shuichi
Kato, Tamotsu
Hara, Kento
Tanaka, Kayo
Kaku, Hiroo
Tajiri, Yuji
Yamada, Kentaro
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E64 - E66
[29] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
Urakami, Tatsuhiko
Habu, Masako
Okuno, Misako
Suzuki, Junichi
Takahashi, Shori
DIABETES, 2014, 63 : A323 - A323
[30] A comparison of the cost-effectiveness for basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart or human insulin-based regimens
Palmer, AJ
Roze, S
Valentine, WJ
Schmidt, I
Wittrup-Jensen, KW
DIABETES, 2004, 53 : A288 - A288

← 1 2 3 4 5 →